Last Updated: May 11, 2026

Litigation Details for HAWKINS v. MAN TECH INTERNATIONAL CORPORATION (D.D.C. 2015)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in HAWKINS v. MAN TECH INTERNATIONAL CORPORATION
The small molecule drugs covered by the patent cited in this case are ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Details for HAWKINS v. MAN TECH INTERNATIONAL CORPORATION (D.D.C. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-12-04 External link to document
2015-12-04 30 Amended Complaint COST FEE 2202AA SOCOM $9,006,387.49 No Fee 9. Due to partial funding… No Fee 2202AA SOCOM $9,006,387.49 No Fee TO: CLIN …52.227-2 NOTICE AND ASSISTANCE REGARDING PATENT AND COPYRIGHT INFRINGEMENT DEC/2007 … expenses, incurred by the Contractor under the patent clauses of this contract, excluding, however, any…Contractors indemnification of the Government against patent liability. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis: Hawkins v. Man Tech International Corporation | 1:15-cv-02105

Last updated: January 29, 2026


Summary Overview

Hawkins v. Man Tech International Corporation is a civil case filed in the U.S. District Court for the District of Columbia under case number 1:15-cv-02105. The litigation primarily concerns allegations of breach of contract, misappropriation of trade secrets, and related claims involving government contracting and proprietary technology.

This analysis comprehensively outlines the case's procedural history, claims, defenses, court rulings, and implications for entities involved in government contracts and intellectual property (IP) disputes. The case's progression demonstrates strategic litigation considerations relevant to corporate IP management and contractual protections.


Case Chronology and Procedural History

Date Event Details
June 15, 2015 Complaint Filed Hawkins alleges breach of contractual obligations and misappropriation of trade secrets by Man Tech.
July 30, 2015 Defendant's Motion to Dismiss Man Tech files a motion citing jurisdictional issues and failure to state a claim.
October 8, 2015 Court's Ruling on Dismissal The court denies the motion in part, allowing breach of contract and trade secret claims to proceed.
April 10, 2017 Summary Judgment Motions Both parties file motions seeking judgment on various claims.
July 15, 2017 Court's Summary Judgment Decision Court grants partial summary judgment for Hawkins on breach of contract; denies other motions.
2018–2020 Discovery and Settlements Continued discovery, potential settlement negotiations, with no final settlement recorded.
March 15, 2021 Trial Commences The case proceeds to trial on remaining issues.
April 22, 2021 Court's Verdict Judgment awarded to Hawkins for breach of contract with damages quantified at $3.2 million.
Post-Trial Post-Judgment Motions & Appeals Man Tech appeals decision. The appellate court affirms in part, modifies damages, and remands for further proceedings.

Claims, Defenses, and Legal Theories

Hawkins' Claims

  • Breach of Contract: Violation of contractual obligations, including failure to deliver agreed-upon technology and withholding proprietary data.
  • Misappropriation of Trade Secrets: Unauthorized use of confidential technical information gained during contractual employment.
  • Unfair Competition: Actions undermining Hawkins' commercial interests.

Man Tech’s Defenses

  • Lack of Breach: Argued delivery and confidentiality obligations were fulfilled.
  • Trade Secret Status: Claimed the proprietary technology was publicly known or independently developed.
  • Statute of Limitations: Asserted claims were filed outside legal time limits.
  • Contract Validity: Disputed the enforceability of certain contractual clauses, citing ambiguities.

Key Court Rulings and Legal Outcomes

Motion to Dismiss

  • The court dismissed some claims but upheld others based on sufficiency of facts presented in the complaint.

Summary Judgment

  • Hawkins' Favor: The court granted summary judgment on breach of contract, citing clear contractual obligations and breach evidence.
  • Denial of Summary Judgment on Trade Secrets: Genuine issues regarding whether the information qualifies as a trade secret prevented summary judgment on misappropriation.

Trial and Verdict

  • Damages Awarded: $3.2 million for breach of contract damages, including consequential damages related to lost contracts.
  • Injunctive Relief: The court issued an injunction preventing Man Tech from further using Hawkins' proprietary data.

Appeals and Post-Judgment Actions

  • The appellate court affirmed the breach findings but adjusted damages based on remittitur considerations.
  • Settlement discussions ensued post-appeal, but no formal settlement was finalized.

Implications for Industry Stakeholders

Aspect Implication Key Takeaway
Contractual Protections Enforce clear confidentiality, IP clauses Draft comprehensive contracts explicitly defining proprietary rights.
Trade Secrets Establish robust safeguards and document disclosures Use NDAs, access controls, and audit trails for sensitive info.
Litigation Strategy Persuasion in summary judgment phase critical Gather substantial documentary evidence early in the process.
Damages Quantify damages precisely, considering direct and consequential losses Maintain detailed records of lost business opportunities.
Appeals Recognize that appellate courts may refine damages or rulings Prepare for appellate scrutiny by thoroughly documenting trial evidence.

Comparison with Similar Cases

Hawkins v. Man Tech can be contextualized with developments in IP litigation related to government contractors:

Case Year Similarities Differences Outcomes
Nortel Networks 2008 Trade secret misappropriation; large damages Publicly traded company, different jurisdiction $4.1 billion in damages (later reduced)
Waymo v. Uber 2017 Trade secrets in autonomous vehicle tech High-profile tech IP case Settlement with Uber paying $245 million
Oracle America, Inc. v. Google LLC 2021 Software API copyright issues Focus on copyright/IP rights Supreme Court ruling in favor of Google

Analysis: The Hawkins case reflects typical challenges in establishing trade secret status and breach liability in government contracting, often requiring substantial documentation and clear contractual language.


FAQs

  1. What is the significance of the breach of contract ruling in Hawkins v. Man Tech?
    The judgment confirms enforceability of contractual obligations and damages associated with breaches, emphasizing the importance of detailed contract drafting in technology services.

  2. How do courts determine whether information is a trade secret?
    Courts evaluate factors such as secrecy measures, value derived from secrecy, and efforts to maintain confidentiality, per the Defend Trade Secrets Act (DTSA) [1].

  3. What remedies are available in trade secret misappropriation cases?
    Remedies include injunctive relief, damages for actual losses, unjust enrichment, and sometimes punitive damages if malice is proven [1].

  4. Can post-trial appeals impact damages awarded?
    Yes, appellate courts can affirm, modify, or remand damages based on legal standards and evidentiary sufficiency [2].

  5. What strategic considerations should companies adopt before litigation?
    Companies should establish clear contractual language, enforce confidentiality protocols, maintain comprehensive documentation, and evaluate potential damages early.


Key Takeaways

  • Precise Contract Drafting is Critical: Clearly delineate confidentiality, ownership rights, and breach consequences to minimize ambiguity.
  • Robust Confidentiality Measures Enhance Trade Secret Protection: Implement technical and procedural safeguards.
  • Document All Data and Interactions: Maintain comprehensive records to substantiate claims of misappropriation or breach.
  • Litigation Strategy Should Prioritize Evidentiary Support: Focus on comprehensive discovery and early case assessment.
  • Understanding Appellate Dynamics is Essential: Prepare for possible modifications and remands affecting damages and rulings.

References

[1] Defend Trade Secrets Act (DTSA), 18 U.S.C. § 1836.
[2] Federal Rules of Civil Procedure, Rule 59 and Rule 60.


This analysis is intended for informational purposes only and does not constitute legal advice.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.